Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Barchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. The company can be reached via phone at 734-369-2555 or via email at [email protected]. Is There a Dimmer Outlook Ahead for Realogy Holdings Corp.? Barchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. View IEX’s Terms of Use. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Learn everything you need to know about successful options trading with this three-part video course. For example, a maximum buy signal is less likely to change to a hold or a sell signal than a weak buy signal. If the total is zero, then this is a "Hold". Earnings for Zomedica Pharmaceuticals Corp (NYSEAMERICAN) are expected to grow in the coming year, from ($0.03) to ($0.02) per share. 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zomedica Pharmaceuticals Corp (NYSEAMERICAN) in the last year. The indicator value is determined by adding up the totals for the different groups and dividing this sum by the number of studies in the group. and has now fallen 4 days in a row.During the day the stock fluctuated 5.88% from a day low … Find out if you should buy ZOM stock. After each calculation, the program assigns a buy, sell or hold value for each study, depending on where the price lies in reference to the common interpretation of the study. The Opinions takes up to 5 years' worth of historical data and runs these prices through thirteen different technical indicators. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Harley Davidson (NYSE: HOG) is Turning the Corner, Enphase Energy (NASDAQ:ENPH) Stock a Buy: Powering Homes With Alternative Energy, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, 7 Stocks That Don’t Care Who Wins the Election, 7 Semiconductor Stocks to Power Your Portfolio, 7 Gold Stocks to Buy Before the Fed Changes Its Mind, Receive Analysts' Upgrades and Downgrades Daily. Zomedica Pharmaceuticals Corp (NYSEAMERICAN)'s mailing address is 100 PHOENIX DRIVE SUITE 190, ANN ARBOR MI, 48108. Want to see which stocks are moving? View which stocks have been most impacted by COVID-19. The direction goes with the signal. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. View analysts' price targets for Zomedica Pharmaceuticals Corp (NYSEAMERICAN). Vote “Outperform” if you believe ZOM will outperform the S&P 500 over the long term. © American Consumer News, LLC dba MarketBeat® 2010-2020. Zomedica Pharmaceuticals Corp stock ended on $0.09 on Monday after losing 4.19% (Updated on October 12, 2020) Sell candidate since 2020-10-01 Loss -11.34% PDF Last Trading Session. Barchart Opinions add market-timing information by calculating and interpreting signal strength and direction. View which stocks are hot on social media with MarketBeat's trending stocks report. ZOM Buy or Sell? Zomedica Pharmaceuticals Corp (NYSEAMERICAN) has a market capitalization of $45.86 million. The trend analysis tool will help you make a better prediction on the ZOM stock. Zomedica Pharmaceuticals Corp holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. The average price from analysts is $0.50. All rights reserved. The company’s stock... Western Digital Corporation (NASDAQ:WDC) went up by 0.72% from its latest closing price compared to the recent 1-year high of $72.00. Identify stocks that meet your criteria using seven unique stock screeners. After this action, POWERS JOHNNY D now owns 625,000 shares of Zomedica Pharmaceuticals Corp., valued at $100,000 using the latest closing price. MarketBeat's community ratings are surveys of what our community members think about Zomedica Pharmaceuticals Corp (NYSEAMERICAN) and other stocks. Zomedica Pharmaceuticals Corp (NYSEAMERICAN) does not currently pay a dividend. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." After each calculation, the program assigns a buy, sell or hold value for each study, depending on where the price lies in reference to the common interpretation of the study. The analysis is useful for short term traders who trade stocks with technical anlaysis. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The Zomedica stock forecast is 0.000000 USD for 2021 October 13, Wednesday with technical analysis. To keep the results in a more logical format, we factor the overall opinion by 1.04 to keep the end result in multiples of 8 percentage points, with the exception of a 100% buy or sell. Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) announced its quarterly earnings data on Monday, August, 10th. Genius Brands International Inc. (NASDAQ:GNUS) went up by 2.14% from its latest closing price compared to the recent 1-year high of $11.73. ZOM Stock Forecast - Get a free ZOM stock predictions and find out whether you should buy or sell ZOM stock. Please read the full disclaimer here. The signal strength is a long-term measurement of the strength of the signal compared to the strength of the signal over the past 200-trading sessions. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. Furthermore, there is currently a sell signal from the 3 months Moving Average Convergence Divergence (MACD). Their forecasts range from $0.50 to $0.50. Get a FREE detailed ZOM analysis report. No stop-loss set. Learn about financial terms, types of investments, trading strategies and more. Zomedica Pharmaceuticals Corp (NYSEAMERICAN) is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. After a stumble in the market that brought ZOM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.78% of loss for the given period. This suggests a possible upside of 515.0% from the stock's current price. Find out if you should buy ZOM stock. It is also developing ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. Users should not base their investment decision upon "StockInvest.us". Is Genius Brands International Inc. (GNUS) a Keeper? Stock Ideas and Recommendations. Get short term trading ideas from the MarketBeat Idea Engine. A break-up above any of these levels will issue buy signals. The company’s... Ross Stores Inc. (NASDAQ:ROST) went down by -0.10% from its latest closing price compared to the recent 1-year high of $124.16.